Accelerate Diagnostics
(OTC) AXDX
Accelerate Diagnostics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$11.70M
Net Income (TTM)
$50.05M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
AXDX News
AXDX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Accelerate Diagnostics
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
107
CEO
Jack Phillips
Website
acceleratediagnostics.comHeadquarters
Tucson, AZ 85714, US
AXDX Financials
Key Financial Metrics (TTM)
Gross Margin
23%
Operating Margin
-3%
Net Income Margin
-4%
Return on Equity
46%
Return on Capital
6%
Return on Assets
-85%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$2.70M
Operating Income
$35.31M
EBITDA
$33.57M
Operating Cash Flow
$24.19M
Capital Expenditure
$509.00K
Free Cash Flow
$24.70M
Cash & ST Invst.
$16.30M
Total Debt
$66.58M
Accelerate Diagnostics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.82M
-6.1%
Gross Profit
$449.00K
-25.9%
Gross Margin
15.94%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
107
N/A
Net Income
$9.59M
+26.2%
EBITDA
$4.36M
+54.0%
Quarterly Fundamentals
Net Cash
$50.28M
-93.4%
Accounts Receivable
$2.04M
-22.3%
Inventory
$2.85M
-13.8%
Long Term Debt
$49.44M
+33.9%
Short Term Debt
$17.14M
+649.7%
Return on Assets
-84.84%
N/A
Return on Invested Capital
6.26%
N/A
Free Cash Flow
$5.07M
+35.6%
Operating Cash Flow
$5.07M
+34.6%